As of 2026-04-16, the Relative Valuation of Cerevel Therapeutics Holdings Inc (CERE) is (57.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc based on Relative Valuation is -227.6%.
The range of the Relative Valuation is (55.86) - (54.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 26.9x | 24.5x |
| Forward P/E multiples | 18.0x - 21.6x | 20.9x |
| Fair Price | (55.86) - (54.49) | (57.37) |
| Upside | -224.2% - -221.2% | -227.6% |
| Date | P/E |